美國體外反搏 (ECP) 設備市場規模、佔有率和趨勢分析報告：按產品、最終用途和細分市場預測，2023-2030 年

美國體外反搏 (ECP) 設備市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，到 2030 年，美國體外反搏（ECP）設備市場規模預計將達到 2.725 億美元，預測期內年複合成長率為 7.6%。

心血管疾病患病的增加和對有效治療的需求推動了成長。 ECP 療法以其非侵入性性和在治療心絞痛和心臟衰竭等疾病方面已被證明的有效性而聞名，並引起了患者和醫療保健提供者的極大興趣。

冠狀動脈疾病患病的上升、冠狀動脈患者動脈粥狀硬化的增加以及心絞痛發作的急劇增加預計將推動外部脈動裝置市場的成長。由於比例患有心絞痛領先患有冠狀動脈疾病的患者以及擴大採用 ECP 設備來治療心絞痛，預計該市場將會成長。 40歲以上患者動脈粥狀硬化的高發生率進一步增加了對ECP治療的需求，因為這個年齡層中近50%的人可能會出現嚴重的動脈粥樣硬化。

由於該行業的技術突破和創新，體外反搏 (ECP) 設備市場正在顯著成長。透過添加先進的監控功能、客製化選項和電子健康記錄系統整合，製造商不斷增強 ECP 設備，以改善患者護理、安全和結果。積極的報銷政策和法律規範正在促進ECP設備在診所和醫院的使用，推動了市場的上升趨勢。此外，市場上的大量競爭以及 FDA 對治療多種心臟疾病的批准預計將推動全球 ECP 設備市場的擴張。

美國體外反搏 (ECP) 設備市場報告亮點

• 2022年，氣動ECP裝置領域佔據壓倒性的市場佔有率，達35.68%。這些裝置利用氣壓來改善流向心臟的血液，有效緩解心絞痛或難治性心絞痛患者的症狀。其非侵入性、成本效益和持續的技術進步使其對患者和醫療保健提供者俱有吸引力。心血管疾病患病的上升進一步推動了這一領域的成長，使其成為心臟病患者有希望的治療選擇。
• 2022年，醫院主導ECP設備市場，佔有率為35.68%。該醫院龐大的患者量、心血管疾病的專業治療、先進的資源和技術以及全面的治療方案使其成為ECP治療的首選。心血管疾病呈上升趨勢，醫院ECP設備的需求預計將進一步增強市場主導地位。
• 主要市場參與企業包括 Vaso Corporation、ACS Diagnostics、Scottcare Corporation 和 Cardiomedics Inc.。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

• 市場區隔和範圍
• 市場體系預測
  • 母市場預測
  • 相關/附隨市場預測
• 市場趨勢及展望
• 市場動態
• 市場抑制因素分析
• 2022 年普及與成長前景預測
• 營商環境分析
  • SWOT 分析；要素因素（政治/法律、經濟/技術）
  • 波特五力分析
• COVID-19感染疾病的影響分析

第4章 美國體外反搏（ECP）設備市場：產品細分分析

• 美國體外反搏 (ECP) 設備市場：2022 年和 2030 年市場佔有率分析
• 氣動ECP裝置
• 心電圖 (ECG) 同步 ECP 裝置
• 擴展體外反搏 (EECP) 裝置

第5章 美國體外反搏（ECP）設備市場：最終用途細分分析

• 美國體外反搏 (ECP) 設備：2022 年和 2030 年市場佔有率分析
• 心臟中心
• 醫院

第6章 競爭形勢

• 公司分類
• 策略規劃
• 2022 年公司市場佔有率分析
• 公司簡介/名單
  • Vaso Corporation
  • ACS Diagnostics
  • Scottcare Corporation
  • Cardiomedics Inc

U.S. External Counterpulsation (ECP) Devices Market Growth & Trends:

The U.S. external counterpulsation (ECP) devices market size is expected to reach USD 272.5 million by 2030, growing at a CAGR of 7.6% during the forecast period, according to a new report by Grand View Research, Inc.. The growth is driven by the increasing prevalence of cardiovascular diseases and the demand for effective treatments. ECP therapy, known for its non-invasive nature and proven efficacy in managing conditions like angina pectoris and heart failure, has garnered significant interest from patients and healthcare providers.

The rise in the prevalence of coronary artery diseases, increase in atherosclerosis in coronary artery patients, and surge in angina episodes are projected to drive the external counterpulsation devices market's growth. With a significant proportion of coronary artery disease cases preceding angina and the rising adoption of ECP devices for managing angina, the market is expected to grow. The incidence of atherosclerosis, most common in patients above 40, further contributes to the demand for ECP therapy, as nearly 50% of individuals in this age group are likely to develop serious atherosclerosis conditions.

Significant growth has been seen in the market for external counterpulsation (ECP) devices, driven by technological breakthroughs and innovations in the industry. By adding advanced monitoring capabilities, customization choices, and electronic medical record system integration, manufacturers continuously enhance ECP devices, improving patient care, safety, and treatment outcomes. Positive reimbursement policies and regulatory frameworks promote the growing use of ECP devices in clinic and hospital settings, which adds to the market's upward trend. Additionally, significant competitors in the market and FDA clearance for treating several cardiac diseases are anticipated to fuel the expansion of the worldwide ECP devices market.

U.S. External Counterpulsation Devices Market Report Highlights:

• In 2022, the pneumatic ECP devices segment held a dominant market share of 35.68%. These devices use air pressure to improve blood flow to the heart, effectively reducing symptoms in angina and refractory angina pectoris patients. Their non-invasive nature, cost-effectiveness, and ongoing technological advancements make them appealing to patients and healthcare providers. The rising prevalence of cardiovascular diseases further fuels the growth of this segment, making it a promising therapeutic option for cardiac patients
• In 2022, hospitals dominated the ECP device market with a share of 35.68%. Their larger patient volumes, specialized care for cardiovascular diseases, access to advanced resources and technologies, and comprehensive treatment options make hospitals the preferred choice for ECP therapy. As cardiovascular diseases continue to rise, the demand for hospital ECP devices is expected to reinforce their market dominance
• Some key market players are Vaso Corporation, ACS Diagnostics, Scottcare Corporation, and Cardiomedics Inc.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information Or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Dynamics
• 3.5. Market Restraint Analysis
• 3.6. Penetration And Growth Prospect Mapping 2022
• 3.7. Business Environment Analysis
  • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
  • 3.7.2. Porter's Five Forces Analysis
• 3.8. COVID-19 Impact Analysis

Chapter 4. U.S. External Counterpulsation (ECP) Devices Market: Product Segment Analysis

• 4.1. U.S. External Counterpulsation (ECP) Devices Market: Market Share Analysis, 2022 & 2030
• 4.2. Pneumatic ECP Devices
  • 4.2.1. Pneumatic ECP Devices Market, 2018 - 2030 (USD Million)
• 4.3. Electrocardiogram (ECG)-Synchronized ECP Devices
  • 4.3.1. Electrocardiogram (ECG)-Synchronized ECP Devices Market, 2018 - 2030 (USD Million)
• 4.4. Enhanced External Counterpulsation (EECP) Devices
  • 4.4.1. Enhanced External Counterpulsation (EECP) Devices Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. External Counterpulsation (ECP) Devices Market: End-Use Segment Analysis

• 5.1. U.S. External Counterpulsation (ECP) Devices: Market Share Analysis, 2022 & 2030
• 5.2. Cardiac Centers
  • 5.2.1. Cardiac Centers Market, 2018 - 2030 (USD Million)
• 5.3. Hospitals
  • 5.3.1. Hospitals Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Strategy Mapping
• 6.3. Company Market Share Analysis, 2022
• 6.4. Company Profiles/Listing
  • 6.4.1. Vaso Corporation
    • 6.4.1.1. Overview
    • 6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Strategic Initiatives
  • 6.4.2. ACS Diagnostics
    • 6.4.2.1. Overview
    • 6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Strategic Initiatives
  • 6.4.3. Scottcare Corporation
    • 6.4.3.1. Overview
    • 6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Strategic Initiatives
  • 6.4.4. Cardiomedics Inc
    • 6.4.4.1. Overview
    • 6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Strategic Initiatives

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. External Counterpulsation (ECP) Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 3 U.S. External Counterpulsation (ECP) Devices Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 U.S. external counterpulsation (ECP) devices market segmentation
• Fig. 8 Market snapshot, 2022
• Fig. 9 Market trends & outlook
• Fig. 10 Market driver relevance analysis (current & future impact)
• Fig. 11 Market restraint relevance analysis (current & future impact)
• Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
• Fig. 13 Porter's five forces analysis
• Fig. 14 Market penetration & growth prospect mapping, 2022
• Fig. 15 U.S. External Counterpulsation (ECP) Devices Market: Product Movement Analysis
• Fig. 16 U.S. External Counterpulsation (ECP) Devices Market, For Pneumatic ECP Devices, 2018 - 2030 (USD Million)
• Fig. 17 U.S. External Counterpulsation (ECP) Devices Market, For Electrocardiogram (ECG)-Synchronized ECP Devices, 2018 - 2030 (USD Million)
• Fig. 18 U.S. External Counterpulsation (ECP) Devices Market, For Enhanced External Counterpulsation (EECP) Devices, 2018 - 2030 (USD Million)
• Fig. 19 U.S. External Counterpulsation (ECP) Devices Market: End-use Movement Analysis
• Fig. 20 U.S. External Counterpulsation (ECP) Devices Market, For Cardiac Centers, 2018 - 2030 (USD Million)
• Fig. 21 U.S. External Counterpulsation (ECP) Devices Market, For Hospitals, 2018 - 2030 (USD Million)